178 related articles for article (PubMed ID: 32985270)
21. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
22. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
23. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
24. Intraocular Pressure Elevation After Posterior Subtenon Triamcinolone Acetonide Injection in Pediatric Non-Infectious Uveitis.
Yalcinsoy KO; Ozdal PC; Sen E; Elgin U
Beyoglu Eye J; 2022; 7(4):298-303. PubMed ID: 36628084
[TBL] [Abstract][Full Text] [Related]
25. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Wang JK; Lin WC
Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
[TBL] [Abstract][Full Text] [Related]
27. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
28. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
29. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.
Sohn EH; Wang R; Read R; Roufas A; Teo L; Moorthy R; Albini T; Vasconcelos-Santos DV; Dustin LD; Zamir E; Chee SP; McCluskey P; Smith R; Rao N
Ophthalmology; 2011 Oct; 118(10):1932-7. PubMed ID: 21708408
[TBL] [Abstract][Full Text] [Related]
30. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
Yang CS; Chen MJ; Chou CK; Hsu WM
Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone.
Hirooka K; Shiraga F; Tanaka S; Baba T; Mandai H
Jpn J Ophthalmol; 2006; 50(3):235-8. PubMed ID: 16767378
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
33. The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection.
Yildirim N; Sahin A; Erol N; Kara S; Uslu S; Topbas S
J Glaucoma; 2008; 17(4):253-6. PubMed ID: 18552607
[TBL] [Abstract][Full Text] [Related]
34. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C
Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Kola M; Hacioglu D; Turk A; Erdol H
Cutan Ocul Toxicol; 2016 Sep; 35(3):185-9. PubMed ID: 26340259
[TBL] [Abstract][Full Text] [Related]
36. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
Karasu B
Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
38. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
[TBL] [Abstract][Full Text] [Related]
39. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Liu X; Wang M; Zhao C; Gao F; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
